Fresenius Medical Care AG & Co. KGaA
FME.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.95B
Close$
Share Statistics
| Market cap | $11.95 Billion |
|---|---|
| Enterprise Value | $22.09 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 7.47% |
|---|---|
| Return on Assets | 3.00% |
| Return on Invested Capital | 7.07% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | 12.95 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.89 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$0.99
Average shareholder expectationRevenue Estimate
$4.42 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.94
Average shareholder expectationRevenue Estimate
$4.63 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fresenius Medical Care AG & Co. KGaA
111,024 employees
CEO: Rice Powell Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcar...